GlaxoSmithKline (GSK) dividend stock





  • Yield

     5.01%
  • Dividend

     80
  • 5 year dividend growth rate
     4.6%
  • Dividend increased

     9 yrs.
  • Payout ratio

     3%
  • Payout ratio (forward)

     69%
  • Ex-dividend date

     5/11/2017
  • Uninterrupted
    dividends
     N/A yrs.
  • Yield compared to 5 year average
     -7.2%
  • Dividend payback
    period
     15 yrs.
  • Chowder rule

     9.6
  • Tweed factor

     -37.5
Rating
Overall rating
The overall rating measures the general health and sustainabilty of the company's dividend. It is an average of the five ratings below.





Dividend increased years
This rating looks at the number of years the company has increased their dividend consecutively. 1 star is given for 7 years or below and 5 stars are given for 23 years or more.





Dividend yield
This rating evaluates the size of the yield. 1 star is given for a yield below 0.75% and 5 stars for yields above 6.75%.





Payout ratio
The payout ratio shows how much of the earnings are being paid out as dividends. We award 0 stars for payout ratios above 100% and 5 stars for ratios below 10%.





Dividend growth rate
This rating takes into account the growth of the dividend. Companies that have a dividend growth rate below 1.5% get 1 star while 5 stars are given for rates above 13.5%.





Yield compared to 5 year average
If the current yield is below the 5 year average, it tends to indicate that the stock is cheap. A rating of 0 is given if the current yield is below 0 percent compared to the average and a rating of 5 is given if it's more than 22.5% above.
Relative valuations
Yield compared to 5 year average   
-7.2%
Payout ratio compared to 5 year average   
-47.5%
P/E compared to 5 year average   
155.7%
Price per book value compared to 5 year average   
369.5%
Price change from 52 week high   
-8.6%
Price change from 50 days average   
-3.8%
Price change from 200 days average   
-2.0%
Price info
Change
19.50 (1.21%)


Last price
1595.50 GBp


Day range
1585.50 - 1616.00


Year range
1446.50 - 1745.56

Financial health
Current ratio
1.24


Debt/equity ratio
187.34


Cash
5.90B


Debt
16.63B


Credit rating
A

Valuation
Price/earning (P/E)
46.79


Price/book (P/B)
46.01


Forward price/earning (P/E)
13.83


Price/sales (P/S)
2.72


PEG
2.11


Market cap
77.96B

Recession performance (2007 - 2009)
51.0000,56.0000,60.0000
  • 2007
  • 2008
  • 2009
Dvidend growth (annualized)   
8.5%
0.9400,0.8800,1.0800
  • 2007
  • 2008
  • 2009
Earnings per share growth (annualized)   
7.2%
10 year history
48.0000,51.0000,56.0000,60.0000,64.0000,68.0000,73.0000,77.0000,80.0000,80.0000
  • 06
  • 07
  • 08
  • 09
  • 10
  • 11
  • 12
  • 13
  • 14
  • ttm
Dividend growth (annualized)   
5.8%
0.9400,0.8800,1.0800,0.3200,1.0300,0.9200,1.1100,0.5700,1.7200,1.7200
  • 07
  • 08
  • 09
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • ttm
Earnings per share growth (annualized)   
6.9%
1.7400,1.5000,1.9300,1.7100,1.4700,1.1900,1.2300,0.9400,1.0100,0.9500
  • 07
  • 08
  • 09
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • ttm
Book value per share growth (annualized)   
-6.5%
54.2000,63.6000,55.4000,200.9000,112.2000,86.5000,101.3000,95.9000,39.6000,46.4000
  • 07
  • 08
  • 09
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • ttm
Payout ratio growth (annualized)   
-1.7%
5.0000,5.0000,5.0000,5.0000,5.0000,4.0000,4.0000,4.0000,4.0000,4.0000
  • 07
  • 08
  • 09
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • ttm
Shares outstanding growth (annualized)   
-2.4%
Other companies in the drug manufacturers - major industry
Company
Div. increase  
Yield
Div. growth
USA   Johnson & Johnson 55 yrs2.53%5.9%
United Kingdom   Dechra Pharmaceuticals 13 yrs0.98%7.0%
USA   Pfizer 7 yrs3.84%8.4%
Company profile
Empoloyees
97,921


Sector


Website


Founded
2000


Industry


GlaxoSmithKline plc creates, discovers, develops, manufactures, and markets pharmaceutical products, including vaccines, over-the-counter medicines, and health-related consumer products worldwide. The company offers pharmaceutical products in the therapeutic areas, including respiratory, anti-virals...
Read More


Address:
980 Great West Road, Brentford, Middlesex, TW8 9GS

Phone:
+44 2080475000
The dividend of GSK is 80 for the last 12 months, and their yield is 5.01%. The company has increased the dividend for 9 years. GSK has a payout ratio of 3%, meaning that 3% of their earnings are paid as dividends. If their dividend growth rate stays the same, the dividend payback period would be 15 years. They have increased their dividend by 4.6% on average in the last 5 years. GlaxoSmithKline has gone ex-dividend on the 5/11/2017. It was founded in 2000 and is a UK company with 97,921 employees. They are in the healthcare sector and the drug manufacturers - major industry. Our dividend rating for this stock is 2.3 / 5 stars.






Sectors      Industries      Dividend dictionary       Contact us

Dividend growth stocks with at least 5 years of dividend increases




Disclaimer: Information on this site is only for informational purposes. Always consult a professional advisor before investing.